Treadmill exercise in apparently asymptomatic patients with moderate or severe aortic stenosis: relationship between cardiac index and revealed symptoms

Heart ◽  
2010 ◽  
Vol 96 (9) ◽  
pp. 689-695 ◽  
Author(s):  
R. Rajani ◽  
H. Rimington ◽  
J. B. Chambers
2021 ◽  
Vol 16 ◽  
Author(s):  
Teresa Sevilla ◽  
Ana Revilla-Orodea ◽  
J Alberto San Román

Aortic stenosis is a very common disease. Current guidelines recommend intervention mainly in symptomatic patients; aortic valve replacement can be considered in asymptomatic patients under specific conditions, but the evidence supporting these indications is poor. Continuous advances in both surgical and percutaneous techniques have substantially decreased rates of perioperative complications and mortality; with this in mind, many authors suggest that earlier intervention in patients with severe aortic stenosis, when they are still asymptomatic, may be indicated. This paper summarises what is known about the natural history of severe aortic stenosis and the scientific evidence available about the optimal timing for aortic valve replacement.


2020 ◽  
Vol 75 (18) ◽  
pp. 2379-2380 ◽  
Author(s):  
Seung-Ah Lee ◽  
Sung-Ji Park ◽  
Sahmin Lee ◽  
Dae-Hee Kim ◽  
Jong-Min Song ◽  
...  

2010 ◽  
Vol 27 (2) ◽  
pp. 105-109 ◽  
Author(s):  
Grace Casaclang-Verzosa ◽  
Joseph F. Malouf ◽  
Christopher G. Scott ◽  
Eldyn Marcony Juracan ◽  
Rick A. Nishimura ◽  
...  

Heart ◽  
2018 ◽  
Vol 104 (22) ◽  
pp. 1836-1842 ◽  
Author(s):  
Sahrai Saeed ◽  
Ronak Rajani ◽  
Reinhard Seifert ◽  
Denise Parkin ◽  
John Boyd Chambers

ObjectiveTo assess the safety and tolerability of treadmill exercise testing and the association of revealed symptoms with outcome in apparently asymptomatic patients with moderate to severe aortic stenosis (AS).MethodsA retrospective cohort study of 316 patients (age 65±12 years, 67% men) with moderate and severe AS who underwent echocardiography and modified Bruce exercise treadmill tests (ETTs) at a specialist valve clinic. The outcome measures were aortic valve replacement (AVR), all-cause mortality or a composite of AVR and all-cause mortality.ResultsAt baseline, there were 210 (66%) patients with moderate and 106 (34%) with severe AS. There were 264 (83%) events. 234 (74%) patients reached an indication for AVR, 145 (69%) with moderate and 88 (83%) with severe AS (p<0.05). Of the 30 (9%) deaths recoded during follow-up, 20 (67%) were cardiovascular related. In total, 797 exercise tests (mean 2.5±2.1 per patient) were performed. No serious adverse events were observed. The prevalence of revealed symptoms at baseline ETT was 29% (n=91) and was significantly higher in severe AS compared with moderate AS (38%vs23%, p=0.008). Symptoms were revealed in 18%–59% of patients during serial ETT conducted over a follow-up period of 34.9 (SD 35.1) months. The event-free survival at 24 months with revealed symptoms was 46%±4% and without revealed symptoms was 70%±4%.ConclusionsETT in patients with moderate or severe AS is safe and tolerable. Serial exercise testing is useful to reveal symptoms not volunteered on the history and adds incremental prognostic information to baseline testing.


Sign in / Sign up

Export Citation Format

Share Document